Myriad Genetics
MYGN
#6699
Rank
โ‚ฌ0.56 B
Marketcap
6,09ย โ‚ฌ
Share price
-3.27%
Change (1 day)
-60.60%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.30 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are โ‚ฌ0.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.31 B-4.53%
2023-12-31โ‚ฌ0.32 B12.66%
2022-12-31โ‚ฌ0.29 B-6.39%
2021-12-31โ‚ฌ0.31 B
2020-06-30โ‚ฌ0.43 B3.84%
2019-06-30โ‚ฌ0.41 B133.23%
2018-06-30โ‚ฌ0.17 B-53.74%
2017-06-30โ‚ฌ0.38 B224.11%
2016-06-30โ‚ฌ0.11 B27.52%
2015-06-30โ‚ฌ93.48 M22.16%
2014-06-30โ‚ฌ76.53 M32.4%
2013-06-30โ‚ฌ57.8 M33.1%
2012-06-30โ‚ฌ43.43 M42.98%
2011-06-30โ‚ฌ30.37 M4.76%
2010-06-30โ‚ฌ28.99 M27.46%
2009-06-30โ‚ฌ22.74 M-51.38%
2008-06-30โ‚ฌ46.79 M78.79%
2007-06-30โ‚ฌ26.17 M23.6%
2006-06-30โ‚ฌ21.17 M8.55%
2005-06-30โ‚ฌ19.5 M57.33%
2004-06-30โ‚ฌ12.39 M-26.66%
2003-06-30โ‚ฌ16.9 M-41.18%
2002-06-30โ‚ฌ28.74 M-25.05%
2001-06-30โ‚ฌ38.34 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Bio-Rad Laboratories
BIO
โ‚ฌ2.54 B 732.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
โ‚ฌ2.91 B 856.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
โ‚ฌ18.73 M-93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ1.33 B 338.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ28.27 B 9,164.57%๐Ÿ‡บ๐Ÿ‡ธ USA